NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 14, 2024 $0.116 -4.91% $0.100 V 84.13% 1
Mar 14, 2024 $0.118 -3.07% $0.100 V 81.89% 1
Mar 14, 2024 Bullish $0.100 X 0
JS JS Pro
Mar 13, 2024 $0.0840 +0.48% $0.122 V 68.80% 1
Mar 13, 2024 $0.0885 +5.88% $0.122 V 72.50% 1
Mar 13, 2024 $0.0867 +3.68% $0.122 V 70.99% 1
JS JS Pro
Mar 12, 2024 $0.0800 -5.44% $0.0836 V 95.69% 1
AlexVel AlexVel Pro
Mar 12, 2024 $0.0839 -0.83% $0.0836 V 99.65% 5
Mar 12, 2024 $0.0897 +6.08% $0.0836 X 92.65% 0
Mar 12, 2024 $0.0878 +3.80% $0.0836 X 94.96% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE